Market Cap | 18.44M | P/E | - | EPS this Y | 35.40% | Ern Qtrly Grth | - |
Income | -13.47M | Forward P/E | -2.06 | EPS next Y | 33.30% | 50D Avg Chg | -17.00% |
Sales | 2.82M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -27.00% |
Dividend | N/A | Price/Book | 3.20 | EPS next 5Y | - | 52W High Chg | -64.00% |
Recommedations | 3.00 | Quick Ratio | 2.33 | Shares Outstanding | 25.93M | 52W Low Chg | 31.00% |
Insider Own | 12.10% | ROA | -109.49% | Shares Float | 19.52M | Beta | 1.06 |
Inst Own | 25.67% | ROE | -214.01% | Shares Shorted/Prior | 308.54K/156.78K | Price | 1.05 |
Gross Margin | -217.56% | Profit Margin | - | Avg. Volume | 175,337 | Target Price | 3.15 |
Oper. Margin | -346.80% | Earnings Date | May 9 | Volume | 270,490 | Change | -0.94% |
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
Alliance Global Partners | Buy | Aug 15, 23 |
Craig-Hallum | Hold | Mar 28, 22 |
Alliance Global Partners | Buy | Dec 3, 21 |
Craig-Hallum | Buy | Nov 15, 21 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Christianson Mark | Business Development.. Business Development Director | Dec 26 | Sell | 1.41 | 38,293 | 53,993 | 300,594 | 12/27/23 |
McClurg Ronald W. | Chief Financial Offi.. Chief Financial Officer | Sep 13 | Buy | 0.9828 | 50,900 | 50,025 | 130,400 | 09/14/23 |
Christianson Mark | Business Development.. Business Development Director | Mar 21 | Sell | 1.54 | 26,500 | 40,810 | 337,494 | 03/24/23 |
McClurg Ronald W. | Chief Financial Offi.. Chief Financial Officer | Jun 15 | Buy | 1.0219 | 10,000 | 10,219 | 67,000 | 06/16/22 |
Christianson Mark | Business Development.. Business Development Director | Jun 23 | Sell | 6.52 | 11,900 | 77,588 | 351,169 | 02/04/22 |